Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Chronic Heart Failure

  Free Subscription


1 Am Heart J
3 Am J Cardiol
1 Cardiovasc Res
11 Eur J Heart Fail
2 J Card Fail
1 J Cardiol
1 J Mol Cell Cardiol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am Heart J

  1. COX ZL, Siddiqi HK, Stevenson LW, Bales B, et al
    Randomized controlled trial of urinE chemiStry guided aCute heArt faiLure treATmEnt (ESCALATE): Rationale and design.
    Am Heart J. 2023 Aug 4:S0002-8703(23)00187-4. doi: 10.1016/j.ahj.2023.
    PubMed         Abstract available

    Am J Cardiol

  2. KAUL S, Siddiqi TJ, Anker SD, Butler J, et al
    Heart Failure Hospitalizations Versus Cardiovascular Mortality in Heart Failure Trials.
    Am J Cardiol. 2023 Aug 7:S0002-9149(23)00596.

  3. PIERCE JB, Blumer V, Choi S, Hardy NC, et al
    Comparative Outcomes of Sacubitril/Valsartan Use After Hospitalization for Heart Failure Among Medicare Beneficiaries Naive to Renin-Angiotensin System Inhibitors.
    Am J Cardiol. 2023;204:151-158.
    PubMed         Abstract available

  4. ZHANG W, He L, Zhang J, Fu G, et al
    Electrical Synchrony Optimization for Left Bundle Branch Area Pacing in Patients With Bradycardia and Heart Failure.
    Am J Cardiol. 2023;203:436-443.
    PubMed         Abstract available

    Cardiovasc Res

  5. KANY S, Al-Taie C, Roselli C, Pirruccello JP, et al
    Association of genetic risk and outcomes in patients with atrial fibrillation: interactions with early rhythm control in the EAST-AFNET4 trial.
    Cardiovasc Res. 2023 Jun 2:cvad027. doi: 10.1093.
    PubMed         Abstract available

    Eur J Heart Fail

  6. KHAN MS, Grayburn PA, Butler J
    Cardiac reverse remodelling with vericiguat: Victory or no victory?
    Eur J Heart Fail. 2023;25:1022-1024.

  7. BHATT AS, Kosiborod MN, Vaduganathan M, Claggett BL, et al
    Effect of dapagliflozin on health status and quality of life across the spectrum of ejection fraction: Participant-level pooled analysis from the DAPA-HF and DELIVER trials.
    Eur J Heart Fail. 2023;25:981-988.
    PubMed         Abstract available

  8. GOLDSMITH AJ, Jin M, Lucassen R, Duggan NM, et al
    Comparison of pulmonary congestion severity using artificial intelligence-assisted scoring versus clinical experts: A secondary analysis of BLUSHED-AHF.
    Eur J Heart Fail. 2023;25:1166-1169.
    PubMed         Abstract available

  9. GREUTMANN M, Tobler D, Engel R, Heg D, et al
    Effect of phosphodiesterase-5 inhibition on SystEmic Right VEntricular size and function. A multicentre, double-blind, randomized, placebo-controlled trial: SERVE.
    Eur J Heart Fail. 2023;25:1105-1114.
    PubMed         Abstract available

  10. COHEN-SOLAL A, Logeart D
    Exercise hypoxaemia in heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2023 Aug 2. doi: 10.1002/ejhf.2989.

  11. PAGNESI M, Serafini L, Adamo M
    Moving towards a comprehensive heart failure management beyond ejection fraction.
    Eur J Heart Fail. 2023 Aug 2. doi: 10.1002/ejhf.2987.

  12. TRULLAS JC, Morales-Rull JL, Casado J, Carrera-Izquierdo M, et al
    Combining loop and thiazide diuretics for acute heart failure across the estimated glomerular filtration rate spectrum: a post-hoc analysis of the CLOROTIC trial.
    Eur J Heart Fail. 2023 Aug 4. doi: 10.1002/ejhf.2988.
    PubMed         Abstract available

  13. FERREIRA JP, Blatchford JP, Teerlink JR, Kosiborod MN, et al
    Mineralocorticoid receptor antagonist use and the effects of empagliflozin on clinical outcomes in patients admitted for acute heart failure: findings from EMPULSE.
    Eur J Heart Fail. 2023 Aug 4. doi: 10.1002/ejhf.2982.
    PubMed         Abstract available

  14. TOMASONI D, Adamo M, Metra M
    July 2023 at a glance: heart failure with preserved ejection fraction and comorbidities.
    Eur J Heart Fail. 2023;25:925-928.

  15. JHA AK
    Phenotypic characterization of heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2023 Aug 10. doi: 10.1002/ejhf.2996.

  16. KHAN MS, Arshad MS, Greene SJ, Van Spall HGC, et al
    Artificial Intelligence and Heart Failure: A State-of-the-Art Review.
    Eur J Heart Fail. 2023 Aug 10. doi: 10.1002/ejhf.2994.
    PubMed         Abstract available

    J Card Fail

  17. SHETTY NS, Parcha V, Patel N, Pampana A, et al
    Incident Heart Failure Risk Reclassification with Race-Independent Estimated Glomerular Filtration Rate: An NHLBI Pooled Cohorts Analysis.
    J Card Fail. 2023 Aug 3:S1071-9164(23)00268.
    PubMed         Abstract available

  18. KHAN MS, Anker SD, Filippatos G, Ferreira JP, et al
    Vascular Disease Burden, Outcomes, and Benefit with Empagliflozin in Heart Failure: Insights from the EMPEROR-Reduced Trial.
    J Card Fail. 2023 Aug 7:S1071-9164(23)00275.
    PubMed         Abstract available

    J Cardiol

  19. ICHIHARA YK, Kohsaka S, Kisanuki M, Sandhu ATS, et al
    Implementation of evidence-based heart failure management: Regional variations between Japan and the USA.
    J Cardiol. 2023 Aug 3:S0914-5087(23)00185-5. doi: 10.1016/j.jjcc.2023.
    PubMed         Abstract available

    J Mol Cell Cardiol

  20. KMIETCZYK V, Oelschlager J, Gupta P, Varma E, et al
    Ythdf2 regulates cardiac remodeling through its mRNA target transcripts.
    J Mol Cell Cardiol. 2023;181:57-66.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.